Key Findings
The North American market for biophotonics is expected to propagate at a CAGR of 9.76% from 2019-2027. This regional market for biophotonics technologies dominates the global biophotonics market because of many factors such as the backing by the increasing investments within the healthcare industry, growing geriatric population base, etc. that are projected to fuel the regional market growth in the coming years.

Market Insights
The increasing investments within the healthcare industry, flooding R&D initiatives and the presence of sophisticated healthcare infrastructure in North America is also attributing to the market growth in the region. The increasing urbanization, the rising rate of smoking habits, obesity and the enlarging population are going to raise the demand of the healthcare sector, which has major applications of biophotonics technologies and devices. Nanotechnology is known to help biophotonics by enhancing the activity or sensing the technology of biophotonics. Thus, further development in the nanotech industry will also profit the biophotonics market.

Competitive Insights
The major market players in the North American biophotonics market are Oxford Instruments, Halma PLC, MKS Instrument, Medlumics SL, Lumenis Ltd., Carl Zeiss AG, OpGen, Fisba AG, Thermo Fisher Scientific Inc., Perkinelmer, Inc., Idex Corp., Becton, Dickinson, And Company, Olympus Corporation, Zecotek Photonics Inc. & Hamamatsu Photonics K.K.